|
- The CHA DS -VASc Score - acforum-excellence. org
A Clarification of Individual Components excellence acforum org Background: Despite a relatively simple tool for categorizing stroke risk in patients with atrial fibrillation, there still remains many questions regarding the definitions and inclu- sions of certain components of the CHA2DS2-VASc Score (Table 1) The validation trial of this score was published in 2010; therefore, the original
- A Clarification of Individual Components
Produced by Stephanie Kaiser, Pharm D , BCPS West Palm Beach VA Medical Center December 2019
- Anticoagulation Forum
Our Centers of Excellence Program The Anticoagulation Centers of Excellence (ACE) program, established in 2012, is dedicated to empowering healthcare professionals to deliver the highest standard of care and achieve optimal outcomes for patients on antithrombotic medications This initiative provides comprehensive access to evidence-based guidelines, regularly updated best practices, and
- Left Ventricular Thrombus excellence. acforum
Background: Left ventricular thrombus (LVT) characteristically occurs in areas of dyskinesia or poorly contracting left ventricular muscle, caused by blood stasis and or endocardial injury with associated inflammation LVT can be a complication of myocardial infarction (MI) and occurs most often with large anterior MI1 The risk of embolization within three months among patients with MI
- Left Ventricular Thrombus (LVT) excellence. acforum
Direct Oral Vitamin K Anticoagulant VS Antagonist Guidance for treatment has been derived primarily from data collected in the post-STEMI population in a pre-PCI, pre-DOAC era DOACs are an attractive treatment strategy as recent meta-analyses of randomized and non-randomized data support equivalent eficacy with DOACs for LVT resolution and SSE, with lower overall bleeding However, DOAC
- WARFARIN DOSING GUIDELINE - acforum-excellence. org
WARFARIN DOSING GUIDELINE PURPOSE: This document is intended as a guide to managing patients requiring warfarin therapy It should be coupled with, and not supersede, clinical judgment Evidence-based tools, such as dosing nomograms, should always be used in conjunction with clinical information pertaining to specific patient characteristics and conditions Inpatient Antithrombosis Stewardship
- Anticoagulation Forum
The Resource Center is a repository of clinical resources and tools, expertly curated all in one place Hundreds of resources are organized by overarching headings from most broad guidance Click here to learn more information
- Thrombophilia Testing – Guidance and Considerations excellence. acfor
Negative thrombo-philia testing does not specifically indicate low VTE risk When assessing ongoing anticoagulation or assuming management of a patient with a known thrombophilia, confirm confirmatory testing was appro-priately performed and interpreted (i e performed off anticoag-ulation, not at the time of acute thrombosis, no interfering medical conditions such as coagulopathy of liver
|
|
|